✦ LIBER ✦

Pegylated liposomal doxorubicin: an efficient treatment in patients with Hodgkin lymphoma relapsing after high dose therapy and stem cell transplation

✍ Scribed by Clozel, Thomas; Deau, Benedicte; Benet, Claire; Franchi, Patricia; Robin, Marie; Madelaine, Isabelle; Thieblemont, Catherine; de Kerviler, Eric; Brière, Josette; Brice, Pauline

Book ID: 125805289
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 68 KB
Volume: 162
Category: Article
ISSN: 0007-1048
DOI: 10.1111/bjh.12428

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment outcome and prognostic factors

Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin’s lymphoma

✍ Lee, S M; Ryder, W D J; Clemons, M J; Morgenstern, G R; Chang, J; Scarffe, J H; 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 67 KB

High-dose therapy and autologous stem ce

High-dose therapy and autologous stem cell rescue for patients with Hodgkin’s disease in first relapse after chemotherapy: results from the EBMT

✍ Sweetenham, J W; Taghipour, G; Milligan, D; Blystad, A K; Caballero, D; Fassas, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 169 KB

High-dose melphalan is an effective salv

High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantation

✍ Gesine Bug; Johannes Atta; Stefan A. Klein; Bernd Hertenstein; Lothar Bergmann; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 107 KB

The remission status before and the PCR

The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin’s lymphoma

✍ Moos, M; Schulz, R; Martin, S; Benner, A; Haas, R 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

High expression of nucleoside transporte

High expression of nucleoside transporter protein hENT1 in Reed–Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin – A CALGB 59804 correlative study

✍ Lai, Raymond; Bartlett, Nancy L.; Mackey, John R.; Jung, Sin-Ho; Johnson, Jeffre 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 438 KB

High dose therapy and autologous stem ce

High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin’s lymphoma: Abstracted from: Federico M, Bellei M, Brice P et al. High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy. Journal of Clinical Oncology 2003; 21: 2320–2325

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 83 KB